Allen B Reitz

Lansdale, PA, United States of America

Allen B Reitz

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 383(Granted Patents)

Forward Citations (Not Self Cited) = 286(Sep 21, 2024)

DiyaCoin DiyaCoin 0.59 

Inventors with similar research interests:


Location History:

  • North Wales, PA (US) (1988)
  • Landsdale, PA (US) (2021)
  • Lansdale, PA (US) (1994 - 2024)


Years Active: 1988-2025

where 'Filed Patents' based on already Granted Patents

100 patents (USPTO):

Title: Allen B Reitz: Pioneering Innovator in the Field of Pharmaceuticals

Introduction:

In the domain of pharmaceuticals, exceptional individuals like Allen B Reitz have made groundbreaking contributions by developing innovative compounds and inventions to combat diseases. With an impressive portfolio of patents and a notable career history, Allen B Reitz has earned recognition as a pioneering innovator. This article explores some of his latest patents, career highlights, and collaborations, shedding light on his remarkable achievements.

Latest Patents:

Allen B Reitz's latest patents demonstrate his ingenuity and dedication to finding solutions for challenging medical conditions. One of his recent inventions is centered around indene derivatives and their potential use in the treatment of cancer. These compounds, formulated based on formula (I), exhibit promising properties for combating this deadly disease.

In addition, Reitz has invented novel quinazolinones that inhibit the formation of tau oligomers, which play a crucial role in neurodegenerative diseases. These compounds offer potential therapeutic benefits for the treatment of neurodegenerative conditions, representing a significant breakthrough in the field. Reitz's patents also cover the preparation of these compounds, their intermediates, and pharmaceutical compositions comprising them.

Career Highlights:

Throughout his career, Allen B Reitz has left an indelible mark within the pharmaceutical industry. He has worked diligently for renowned companies, including Janssen Pharmaceutica N.V. and Ortho-McNeil Pharmaceutical Corp., where he contributed significantly to research and development efforts. Reitz's expertise and dedication have propelled him forward, resulting in an impressive portfolio of 83 patents.

Collaborations:

Within the collaborative realm, Allen B Reitz has had the opportunity to work with accomplished professionals who share his passion for scientific exploration. Notable colleagues such as Garry Robert Smith and Tina Morgan Ross have joined forces with Reitz to strive for advancements in pharmaceutical research. Collaborations such as these have fostered a fertile environment for innovative ideas and expedited the development of novel inventions.

Conclusion:

Allen B Reitz stands as an exemplary figure in the field of pharmaceuticals, highlighting the power of innovation and ingenuity in battling diseases. His latest patents, focused on developing effective treatments for cancer and neurodegenerative conditions, portray his commitment to improving the lives of patients worldwide. With an extensive career history and influential collaborations, Reitz's contributions have made a lasting impact on the pharmaceutical industry. As we look ahead to the future, we eagerly anticipate the next wave of innovations from visionaries like Allen B Reitz.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…